Siemens 3.0T SKYRA MRI

Siemens MAGNETOM Skyra 3.0T MRI is the most advanced 3.0T MRI system internationally, offering faster scanning speed, higher image quality, and a broader range of clinical applications. It provides irreplaceable diagnostic value for diseases of the nervous system, cardiovascular system, abdomen, pelvis, musculoskeletal system, and joints.

Advantages and Features of Siemens 3.0T SKYRA MRI

1、Short magnet, 70 cm wide bore, and integrated coil design make MRI examinations more patient-friendly, allowing safe, non-invasive, and radiation-free scans for obese patients, those with claustrophobia, and patients with ankylosing spondylitis.

2、Silent imaging platform: Special sequence designs reduce vibrations of the gradient coils during scanning, lowering noise and providing a more comfortable examination experience for patients.

3、Blade-based artifact reduction (BLADE): Applicable to all body regions, including head, spine, joints, abdomen, and pelvis. It overcomes challenges in obtaining clear images from children, patients with impaired consciousness, or claustrophobic individuals.

【IMG1】

4、High-resolution diffusion imaging (High-resolution DWI): Reduces magnetic susceptibility artifacts and minimizes phase errors caused by physiological motion.

【IMG2】

Applicable Patient Populations for Siemens 3.0T SKYRA MRI

1. General Examination Population

Patients requiring morphological imaging and routine screening of all body regions, including the nervous system, head and neck, thorax, abdomen, pelvis, spine, and limb joints.

2. Oncology Patients

For early screening, diagnostic staging, and treatment evaluation of malignant tumors, especially for patients needing high soft-tissue resolution, such as breast cancer (particularly dense breasts), liver cancer, pancreatic cancer, and prostate cancer.

3. Cardiovascular Patients

Assessment of cardiac morphology and function, myocardial viability analysis, congenital heart disease and coronary artery disease diagnosis. Non-invasive vascular imaging (MRA) can evaluate aneurysms, vessel stenosis, and plaque stability.

4. Neurological Patients

Diagnosis of brain tumors, cerebrovascular lesions (acute cerebral infarction can be detected within 2 hours using DWI sequences), epilepsy, Alzheimer's disease, Parkinson's disease, and other functional neurological disorders.

5. Special Populations

• Obese patients and those with claustrophobia

• Pediatric and elderly patients

• Patients with liver or kidney dysfunction

• Trauma patients and those unable to cooperate

6. Patients Requiring Functional Imaging

Functional assessments including DWI, MRS, DTI, SWI, BOLD, and perfusion imaging, allowing analysis of lesion metabolism and functional status at molecular and cellular levels.

【IMG3】

【IMG4】